Valuation: Quest Diagnostics Incorporated

Market Cap 27.02B 145B 24.22B 22.37B 20.28B 37.79B 2,573B 38.31B 268B 107B 1,347B 101B 99.25B 4,263B P/E 2026 *
23.8x
P/E 2027 * 22.4x
Enterprise Value 32.01B 171B 28.69B 26.5B 24.02B 44.77B 3,048B 45.38B 317B 126B 1,595B 120B 118B 5,050B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.48x
Free-Float
67.61%
Yield 2026 *
1.35%
Yield 2027 * 1.34%
1 day-5.57%
3 months+2.86%
6 months+15.33%
Current year+20.45%
Current year 478.31
Extreme 478.31
613.8
1 year 478.31
Extreme 478.31
613.8
3 years 307.83
Extreme 307.83
613.8
5 years 307.83
Extreme 307.83
613.8
10 years 189
Extreme 189
613.8
Manager TitleAgeSince
Chief Executive Officer 63 03/02/2022
Director of Finance/CFO 56 11/07/2022
Chief Tech/Sci/R&D Officer - 06/05/2024
Director TitleAgeSince
Director/Board Member 76 01/12/2004
Director/Board Member 68 07/12/2011
Chairman 63 01/04/2023
Change 5-day change 1-year change 3-year change Capi.($)
-5.57%-.--% - - 26.69B
-1.29%-5.07%+9.10%+35.69% 117B
+2.95%-0.54%-0.99%+105.61% 97.42B
+3.31%+4.56%+120.80%+1,009.30% 59.22B
+0.17%+2.97%-6.19%+89.51% 29.03B
+8.78%+11.49%+30.69%+81.07% 26.86B
+1.26%+3.58%+36.26%+92.37% 26.69B
+2.46%-1.40%+24.21%+405.46% 21.1B
+0.95%+2.20%-16.82%-0.93% 20.61B
-0.13%-1.01%-6.23%+31.16% 16.94B
Average +1.51%-0.26%+21.20%+205.47% 46.05B
Weighted average by Cap. +1.77%-1.40%+23.62%+218.43%

Financials

2026 *2027 *
Net sales 12.08B 64.64B 10.83B 10B 9.07B 16.9B 1,151B 17.13B 120B 47.69B 602B 45.33B 44.38B 1,906B 12.62B 67.52B 11.31B 10.45B 9.47B 17.65B 1,202B 17.89B 125B 49.81B 629B 47.35B 46.36B 1,991B
Net income 1.16B 6.23B 1.04B 963M 873M 1.63B 111B 1.65B 11.53B 4.59B 57.99B 4.37B 4.27B 184B 1.24B 6.62B 1.11B 1.02B 928M 1.73B 118B 1.75B 12.25B 4.88B 61.64B 4.64B 4.54B 195B
Net Debt 4.99B 26.68B 4.47B 4.13B 3.74B 6.97B 475B 7.07B 49.4B 19.68B 249B 18.71B 18.32B 787B 4.34B 23.2B 3.89B 3.59B 3.25B 6.07B 413B 6.15B 42.96B 17.11B 216B 16.27B 15.93B 684B
Projected Income Statement - Annual - Quest Diagnostics Incorporated
Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.7%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica-pathology diagnostic services; - other (2.3%).
Employees
51,500
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Quest Diagnostics Incorporated
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
245.62USD
Average target price
257.27USD
Spread / Average Target
+4.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Quest Diagnostics Incorporated